Yahoo · Sep 29, 2026
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure
NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.
NASDAQ · NAII
Consumer Defensive · Packaged Foods
$1.06
Up+$0.02 (+1.89%)
Updated Nov 4, 2026, 8:59 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NAII
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
NAII closed at $1.06 after 21 trading sessions, down 20.30% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.08 | $1.0802 | $1.06 | $1.06 | 5.1K |
| Nov 2, 2026 | $1.09 | $1.1399 | $1.07 | $1.07 | 14.5K |
| Oct 30, 2026 | $1.13 | $1.13 | $1.07 | $1.07 | 2.69K |
| Oct 29, 2026 | $1.145 | $1.145 | $1.07 | $1.11 | 38.02K |
| Oct 28, 2026 | $1.13 | $1.17 | $1.10 | $1.16 | 10.67K |
| Oct 27, 2026 | $1.13 | $1.16 | $1.12 | $1.13 | 1.53K |
| Oct 26, 2026 | $1.13 | $1.21 | $1.13 | $1.15 | 5.19K |
| Oct 23, 2026 | $1.22 | $1.22 | $1.15 | $1.21 | 6.8K |
| Oct 22, 2026 | $1.20 | $1.215 | $1.20 | $1.20 | 16.68K |
| Oct 21, 2026 | $1.16 | $1.19 | $1.15 | $1.19 | 1.97K |
| Oct 20, 2026 | $1.15 | $1.26 | $1.145 | $1.16 | 54.35K |
| Oct 19, 2026 | $1.1501 | $1.1591 | $1.15 | $1.15 | 11.33K |
| Oct 16, 2026 | $1.15 | $1.19 | $1.15 | $1.15 | 25.55K |
| Oct 15, 2026 | $1.185 | $1.19 | $1.101 | $1.12 | 5.18K |
| Oct 14, 2026 | $1.14 | $1.17 | $1.08 | $1.14 | 31.59K |
| Oct 13, 2026 | $1.21 | $1.315 | $1.15 | $1.15 | 30.11K |
| Oct 12, 2026 | $1.13 | $1.34 | $1.13 | $1.22 | 63.72K |
| Oct 9, 2026 | $1.18 | $1.42 | $1.11 | $1.14 | 94.38K |
| Oct 8, 2026 | $1.26 | $1.38 | $1.12 | $1.145 | 48.97K |
| Oct 7, 2026 | $1.33 | $1.42 | $1.21 | $1.29 | 34.17K |
| Oct 6, 2026 | $1.525 | $1.525 | $1.31 | $1.33 | 24.41K |
The latest Smart Investors Daily articles mentioning NAII.
Company
Market Activity
Research & News
NAII research
Company profile and research snapshot.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 29, 2026
NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.
Yahoo · Sep 28, 2026
CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $13.5 million, or ($2.23) per diluted share, on net sales of $34.5 million for the fourth quarter of fiscal year 2026 compared to a net loss of $7.2 million, or ($1.20) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth
Benzinga · Sep 28, 2026
Natural Alternatives Intl (NASDAQ:NAII) reported quarterly losses of $(0.52) per share. This is a 56.67 percent increase over losses of $(1.20) per share from the same period last year. The company reported $34.508
Benzinga · Sep 28, 2026
Natural Alternatives Intl (NASDAQ:NAII) reported quarterly losses of $(2.23) per share. This is a 85.83 percent decrease over losses of $(1.20) per share from the same period last year. The company reported $34.508
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NAII.